Methods and compositions for inducing apoptosis
View Patent ↗The C-terminal domain of focal adhesion kinase (FAK-CD) was isolated using a Baculoviral system. Using phage display techniques, a phage encoding a 12 amino-acid peptide (peptide 35) and AV3 that binds to FAK-CD were identified. The peptides were also conjugated to TAT-FITC to produce a fluorescently labeled chimeric molecule capable of penetrating cell membranes. Contacting various breast cancer cell lines with these molecule caused detachment, rounding, apoptosis and cell death. These effects were not observed in normal (non-cancerous) breast cells.
1. An isolated peptide that specifically binds focal adhesion kinase and induces apoptosis in a cell that expresses focal adhesion kinase; wherein said peptide consists of the amino acid sequence of SEQ ID NO: 3.
2. A chimeric molecule that comprises the peptide of claim 1 and a membrane permeabilization domain.
3. A composition comprising the chimeric molecule of claim 2 .
4. A composition comprising a chimeric molecule, wherein the chimeric molecule comprises the peptide of claim 1 , and a targeting domain.
5. A composition comprising a chimeric molecule comprising a targeting domain and the peptide of claim 1 or a variant thereof, wherein said variant is at least 90% identical to SEQ ID NO: 3, wherein the chimeric molecule binds focal adhesion kinase.
6. The composition of claim 5 , wherein the targeting domain is a membrane permeabilization domain.
7. The composition of claim 6 , wherein the membrane permeabilization domain is an HIV TAT domain.
8. The composition of claim 5 , wherein the targeting domain is an antibody that binds a tumor antigen.
9. The composition of claim 8 , wherein the tumor antigen is selected from the group consisting of HER-2/neu; intestinal carboxyl esterase; alpha-fetoprotein; M-CSF; MUC1; p53; PRAME; PSMA; RAGE-1; RU2AS; survivin; Telomerase; WT1; and CA125.
10. A composition comprising an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 3, or a variant thereof, wherein said variant is at least 90% identical to SEQ ID NO: 3, wherein the peptide or variant binds focal adhesion kinase (FAK), induces cellular apoptosis and inhibits cell motility.
11. The composition of claim 10 , wherein the composition is administered to a cell.
12. The composition of claim 10 , wherein the peptide or variant induces apoptosis in a tumor.
13. The composition of claim 10 , wherein the peptide or variant inhibits cell motility.
14. A composition comprising an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 3.